Expression of histone demethylase JMJD2D in lung adenocarcinoma and its prognostic implication
10.13315/j.cnki.cjcep.2023.11.014
- VernacularTitle:肺腺癌中组蛋白去甲基化酶JMJD2D的表达及预后分析
- Author:
Yue CHEN
1
;
Yinghong YANG
Author Information
1. 福建医科大学附属协和医院病理科,福州 350001;福建省妇幼保健院病理科,福州 350001
- Keywords:
lung neoplasm;
adenocarcinoma;
JMJD2D;
cell cycle;
single-cell;
prognosis
- From:
Chinese Journal of Clinical and Experimental Pathology
2023;39(11):1356-1361
- CountryChina
- Language:Chinese
-
Abstract:
Purpose To analyze the expression and prog-nostic role of JMJD2D in lung adenocarcinoma.Methods In this study,the expression of JMJD2D mRNA in lung adenocarci-noma and prognosis were analyzed using TCGA and GEO data-bases.The protein expression and prognostic value of JMJD2D in lung adenocarcinoma were further validated by immunohisto-chemistry.GSEA analysis was performed to identify signaling pathways associated with JMJD2D,with review of the relevant literature.Results The expression of JMJD2D mRNA in lung adenocarcinoma in TCGA database(513 cases of lung adenocar-cinoma and 59 cases of paracancerous tissue)and GEO database(46 cases of lung adenocarcinoma and 45 cases of adjacent tis-sue)were significantly higher than those in the paracancerous tissues.Survival analysis showed that the overall survival of pa-tients with low expression of JMJD2D mRNA was significantly higher than that of patients with high expression,and high ex-pression of JMJD2D mRNA was associated with poor prognosis in patients with lung adenocarcinoma.The expression of JMJD2D in 208 cases of lung adenocarcinoma was higher(96.15％)than that in adjacent tissues(9.13％)(P＜0.001),and its high expression was related to the prognosis.The results of GSEA analysis showed that JMJD2D high expression was signifi-cantly enriched in DNA damage repair,DNA replication and cell cycle regulation.Conclusion This study identifies high expres-sion of JMJD2D as an adverse prognostic factor in lung adenocar-cinoma.Further research on JMJD2D may provide new thera-peutic targets for lung adenocarcinoma.
